drugset

drugset / Trial / NCT03014375

Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites

NCT03014375 ↗

Phase 1 Completed 4 enrolled Bial - Portela C S.A.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to: To determine the rate and routes of excretion of BIA 5-453 and the mass balance in urine and faeces

Timeline

Start: 2008-09
Primary completion: 2008-10
Completion: 2008-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BIA 5-453	Unknown	600 mg	Oral

Indications